Moreover, the bioavailability of testosterone and estradiol is increased in obesity due to hyperinsulinemia and elevated IGF-1 activity, resulting in decreased hepatic production of SHBG [31]. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.